Alphatec beats Q3 revenue expectations, raises full-year revenue guidance

Alphatec Holdings

30/10/2025 20:19

Overview

Alphatec Q3 revenue grew 30% to $197 mln, beating analyst expectations

Adjusted EBITDA for Q3 was $26 mln, surpassing analyst estimates

Company raises full-year revenue and profitability guidance

Outlook

Alphatec raises full-year revenue guidance to $760 mln from $742 mln

Company expects full-year adjusted EBITDA of $91 mln, up from $83 mln

Result Drivers

SURGICAL REVENUE - Co attributes 31% growth in surgical revenue to continued momentum of PTP and LTP solutions

EOS REVENUE - EOS revenue grew by 29% YoY as EOS Insight adoption increased

NEW SURGEON USERS - Achieved 26% growth in net new surgeon users, a key leading indicator of future growth

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Beat
$197 mln
$182.8 mln (9 Analysts)
Q3 Net Income
-$29 mln
Q3 Adjusted EBITDA
Beat
$26 mln
$19.9 mln (7 Analysts)
Q3 Gross Margin
70%
Q3 Adjusted Gross Margin
70%
Q3 Basic EPS
-$0.19
Q3 Operating Income
-$15.93 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"

Wall Street's median 12-month price target for Alphatec Holdings Inc is $20.00, about 17.6% above its October 29 closing price of $16.49

Press Release: ID:nBw4Gwjhba

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)